Imaging AI in Illinois

Abbott is a global healthcare company headquartered in Abbott Park, Illinois, serving approximately 2 billion people worldwide with life-changing technology across diagnostics, medical devices, nutrition, and pharmaceuticals. The company manufactures and distributes a diverse portfolio of medical diagnostic equipment, devices, and consumer health products. Notable product lines include the Lingo Glucose System for continuous glucose monitoring in non-insulin users, advanced cancer testing and diagnostics solutions (including Exact Sciences partnership), cardiac monitoring systems, and point-of-care diagnostic equipment. Abbott operates across multiple therapeutic areas including cardiology, oncology, diagnostics, and nutrition. The company maintains FDA 510(k) clearances and CE marking for various medical devices and diagnostic platforms. Abbott distributes products globally through direct sales, healthcare partnerships, and retail channels, with significant presence in hospital systems, clinical laboratories, and home-care settings. The organization emphasizes innovation in precision diagnostics, digital health integration, and patient monitoring technologies.

Brainlab is a Munich-headquartered medical technology company specializing in digital surgical ecosystems, robotic-assisted surgery, and intraoperative imaging platforms. The company designs integrated software and hardware solutions for neurosurgery, orthopedic spine surgery, radiosurgery, and craniomaxillofacial procedures. Core product lines include the Brainlab Robotic Suite (robotic-assisted surgical systems), Loop-X (mobile robotic intraoperative CBCT imaging), Spine Mixed Reality Navigation, spinal planning software, Elements (radiosurgery planning and automation), and Craniomaxillofacial Planning software. Brainlab also manufactures surgical navigation systems, mixed-reality visualization platforms, and ultrasound-based intraoperative guidance tools. The company markets solutions globally to hospitals and surgical centers, supporting minimally invasive and open procedures. Regulatory credentials include CE marking and FDA clearances; the site references 510(k) submissions and compliance with international standards. Brainlab operates worldwide with headquarters in Munich-Riem, Germany, and maintains regional presence across North America, Europe, and Asia-Pacific. The company emphasizes end-to-end surgical ecosystem integration, enabling preoperative planning through intraoperative execution and has partnerships with academic medical centers and large health systems.

GE HealthCare is a diversified multinational medical technology and digital solutions company with over 130 years of healthcare innovation history. The company develops and manufactures a broad portfolio of diagnostic imaging equipment, patient monitoring devices, anesthesia delivery systems, maternal and infant care solutions, and clinical consumables. Key product categories include CT scanners (including the recently FDA-cleared Photonova™ Spectra photon-counting CT), ultrasound systems, diagnostic ECG equipment, anesthesia machines, and contrast media. GE HealthCare operates globally with an installed base exceeding 5 million units and serves approximately 1 billion patients annually. The company has invested over $5.1 billion in R&D and product development since 2022 and leads the FDA's list of AI-enabled medical device authorizations with 110+ clearances. GE HealthCare offers integrated digital solutions including PACS, cloud-first enterprise platforms (as evidenced by the Intelerad acquisition), and clinical decision support software. The company holds FDA 510(k) clearances, CE marking, and other regulatory credentials across its device portfolio. Manufacturing, service, and support capabilities span multiple continents, supporting hospitals, healthcare systems, and clinical facilities worldwide.

SimBioSys develops cloud-based AI and spatial biophysics software for precision cancer visualization, diagnosis, and treatment planning. The company's core technology combines artificial intelligence, spatial biophysics, and data science to segment tumors and create interactive 3D digital models from medical imaging (primarily DCE-MRI), addressing tumor heterogeneity beyond traditional 2D pathology. TumorSight Viz is the company's flagship product—FDA-cleared for breast cancer surgical planning and preoperative assessment. It transforms 2D MRI studies into 3D visualizations with volumetric calculations and anatomical measurements to support breast conservation decisions. Additional clinical solutions in development include TumorSight Plan (surgical guidance), TumorSight IQ (treatment response prediction), TumorSight Risk (recurrence risk assessment), TumorSight Marker (biomarker selection), and TumorSight Dose (therapeutic dosing). PhenoScope is a research platform supporting biomarker discovery, optimal dosing, combination therapy analysis, and indication expansion. The company serves breast surgeons, oncologists, academic medical centers, and biopharma researchers. Institutional partnerships include Baylor College of Medicine, NYU Langone Health, Yale Medicine, and NorthShore Health. The technology leverages NVIDIA infrastructure for 3D model generation. While TumorSight Viz holds FDA clearance, most advanced clinical applications remain investigational. SimBioSys positions itself at the intersection of precision medicine, surgical planning, and AI-driven oncology diagnostics.

Sibel Health is an FDA-cleared digital health company specializing in wireless vital signs monitoring solutions for neonatal, maternal, adult, and remote care settings. The company's flagship ANNE® One platform delivers continuous, real-time vital signs tracking through wearable wireless sensors that integrate with mobile devices and clinical information systems. Sibel's technology enables proactive monitoring and data-driven clinical decision support across multiple care environments—including hospital-based clinical care, remote patient monitoring, hospital-at-home programs, and global health initiatives. The platform supports advanced applications in neonatal intensive care, maternal wellness tracking, personalized adult care interventions, and research/clinical trials. Sibel has deployed systems across 20+ countries and partners with leading organizations including Samsung and Maruho Co., Ltd. The company emphasizes engineering excellence, peer-reviewed validation, and accessibility for under-resourced healthcare settings.